BDBM590790 6-(5-fluoropyridin-2-yl)-1-(2- morpholinoethyl)-2-oxo-N- (spiro[3.3]heptan-2-yl)-1,2- dihydro-1,8-naphthyridine-3-carboxamide::US11564928, Compound 37

SMILES Fc1ccc(nc1)-c1cnc2n(CCN3CCOCC3)c(=O)c(cc2c1)C(=O)NC1CC2(CCC2)C1

InChI Key InChIKey=AQKJBGBMUWJROM-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 590790   

TargetCannabinoid receptor 1(Homo sapiens (Human))
Teon Therapeutics

US Patent
LigandPNGBDBM590790(6-(5-fluoropyridin-2-yl)-1-(2- morpholinoethyl)-2-...)
Affinity DataIC50:  112nMAssay Description:CB1R binding protocol involves the use of the same solution buffer used for both incubation and washing reaction (Tris-HCl, 50 mM; EDTA, 2.5 mM; MgCl...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
Teon Therapeutics

US Patent
LigandPNGBDBM590790(6-(5-fluoropyridin-2-yl)-1-(2- morpholinoethyl)-2-...)
Affinity DataIC50:  0.600nMAssay Description:CB1R binding protocol involves the use of the same solution buffer used for both incubation and washing reaction (Tris-HCl, 50 mM; EDTA, 2.5 mM; MgCl...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent